Department of Surgery, Wright State University, Dayton, Ohio, USA.
Surg Obes Relat Dis. 2013 Jan-Feb;9(1):21-5. doi: 10.1016/j.soard.2012.08.014. Epub 2012 Sep 6.
Laparoscopic sleeve gastrectomy (SG) is the most recent bariatric surgical procedure to gain universal acceptance by providers and payers. Long-term clinical data on outcomes is limited at this time.
We retrospectively examined 5-year outcomes (weight loss, complications, and resolution of co-morbid conditions) of patients undergoing SG at our institution.
Our initial SG was performed in 2005, and we operated on 55 consecutive patients who are 5 years out from surgery. Six patients were excluded from the long-term results. Four patients underwent conversion to a duodenal switch, and 2 patients died in the first year outside the perioperative period. Average starting body mass index was 65 kg/m(2). Five-year average percent excess weight loss was 86% (range 50%-103%). Percentage of co-morbidities resolved: hypertension (95%), type 2 diabetes mellitus (100%), hyperlipidemia (100%), and obstructive sleep apnea (100%). Gastroesophageal reflux disease (GERD) was resolved in 53%, and new GERD symptoms developed in 11% of patients. There was 1 staple line leak (1.9%), no strictures, no gastrointestinal bleeding, and no perioperative deaths.
In this study, SG is a well-tolerated and effective bariatric surgical procedure with good long-term weight loss and resolution of co-morbid medical conditions.
腹腔镜袖状胃切除术（SG）是最近一种获得提供者和支付者广泛认可的减肥手术。目前，关于该手术的长期临床结果数据有限。
我们回顾性分析了本机构接受 SG 治疗的患者 5 年的结果（减重、并发症和合并症的缓解情况）。
我们最初的 SG 手术于 2005 年进行，对 55 例术后 5 年的连续患者进行了研究。有 6 例患者被排除在长期结果之外。有 4 例患者转为十二指肠转流术，2 例患者在围手术期外的第一年死亡。平均起始体重指数为 65kg/m²。5 年平均超重体重减轻百分比为 86%（范围为 50%-103%）。缓解的合并症百分比：高血压（95%）、2 型糖尿病（100%）、高血脂（100%）和阻塞性睡眠呼吸暂停（100%）。胃食管反流病（GERD）缓解率为 53%，11%的患者出现新的 GERD 症状。有 1 例吻合口漏（1.9%）、无狭窄、无胃肠道出血，也无围手术期死亡。
在这项研究中，SG 是一种耐受性良好且有效的减肥手术，具有良好的长期减重效果和合并症缓解效果。
